MILWAUKEE, July 23,
2024 /PRNewswire/ -- Versiti, Inc., a national
leader in innovative blood health solutions, announced today the
promotion of Matthew Anderson, MD,
PhD, to Executive Vice President and Chief Medical Officer.
Currently serving as Vice President and Medical Director of
Versiti's Diagnostic Labs, Dr. Anderson will now lead the
organization's Medical Sciences Institute (MSI), providing
strategic leadership and guiding innovative research and clinical
programs.
"We are thrilled to promote Matt into this role. His career
trajectory, starting at our Versiti Blood Research Institute,
highlights our commitment to intentional leadership succession and
development," said Chris Miskel,
president and CEO of Versiti. "Matt's diverse experience,
reputation in the industry, and collaborative approach to leading
teams and enhancing patient care make him an ideal fit to further
Versiti's mission."
Dr. Anderson succeeds Dr. Barbara
Bryant, who has successfully led the MSI for the past two
years. He will assume his new role on July
29, 2024, ensuring a smooth transition and continued
momentum of Versiti's life-saving mission.
A native of California, Dr.
Anderson graduated from UC San Diego. He pursued an MD/Ph.D. at the
Medical College of Wisconsin,
conducting his Ph.D. research at the Versiti Blood Research
Institute. He completed programs in anatomic pathology and
hematopathology at Stanford University,
followed by fellowships in molecular pathology and
histocompatibility. In 2011, Dr. Anderson joined the Stanford faculty as an assistant professor and
assistant director of the Histocompatibility, Immunogenetics, and
Disease Profiling Laboratory.
Dr. Anderson returned to Versiti in 2013 as the medical director
for the Wisconsin Diagnostic Laboratories. He was promoted to vice
president in 2017, expanding his leadership to include Cenetron
Diagnostics and Salus IRB.
"As blood health innovators, we are passionate about advancing
scientific knowledge and clinical practice in transfusion medicine,
hematology, and transplantation," said Dr. Anderson. "I am excited
to have the opportunity to lead our medical science teams in
creating new innovative solutions for patient care."
Dr. Anderson is also an active member of the community, serving
on professional committees and supporting biohealth initiatives in
Wisconsin.
Versiti, headquartered in Milwaukee, has more than 2,300 employees at
its locations in Illinois,
Indiana, Michigan, Ohio, Texas
and Wisconsin. For more
information, visit Versiti.org.
About Versiti
Versiti, a national leader in blood
health innovation, was formed with the mission to improve the
health of patients and enable the success of our healthcare
partners nationally. We provide innovative, value-added solutions
in the fields of transfusion medicine, transplantation, and
blood-related diseases to meet the needs of each of our customers.
The collective efforts across Versiti result in improved patient
outcomes, expanded access to care, and cost efficiencies for
healthcare systems nationwide. For more information, visit
Versiti.org.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/versiti-inc-names-matthew-anderson-md-phd-executive-vp-and-chief-medical-officer-302204418.html
SOURCE Versiti, Inc.